Literature DB >> 17369858

Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-kappaB activation and endothelial cell survival.

G Bieler1, M Hasmim, Y Monnier, N Imaizumi, M Ameyar, J Bamat, L Ponsonnet, S Chouaib, M Grell, S L Goodman, F Lejeune, C Rüegg.   

Abstract

Tumor necrosis factor (TNF) is a pro-inflammatory cytokine exerting pleiotropic effects on endothelial cells. Depending on the vascular context it can induce endothelial cell activation and survival or death. The microenvironmental cues determining whether endothelial cells will survive or die, however, have remained elusive. Here we report that integrin ligation acts permissive for TNF-induced protein kinase B (PKB/Akt) but not nuclear factor (NF)-kappaB activation. Concomitant activation of PKB/Akt and NF-kappaB is essential for the survival of endothelial cells exposed to TNF. Active PKB/Akt strengthens integrin-dependent endothelial cell adhesion, whereas disruption of actin stress fibers abolishes the protective effect of PKB/Akt. Integrin-mediated adhesion also represses TNF-induced JNK activation, but JNK activity is not required for cell death. The alphaVbeta3/alphaVbeta5 integrin inhibitor EMD121974 sensitizes endothelial cells to TNF-dependent cytotoxicity and active PKB/Akt attenuates this effect. Interferon gamma synergistically enhanced TNF-induced endothelial cell death in all conditions tested. Taken together, these observations reveal a novel permissive role for integrins in TNF-induced PKB/Akt activation and prevention of TNF-induced death distinct of NF-kappaB, and implicate the actin cytoskeleton in PKB/Akt-mediated cell survival. The sensitizing effect of EMD121974 on TNF cytotoxicity may open new perspectives to the therapeutic use of TNF as anticancer agent.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369858     DOI: 10.1038/sj.onc.1210354

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Cyclopeptide RA-V inhibits angiogenesis by down-regulating ERK1/2 phosphorylation in HUVEC and HMEC-1 endothelial cells.

Authors:  Grace G L Yue; Jun-Ting Fan; Julia K M Lee; Guang-Zhi Zeng; Tina W F Ho; Kwok-Pui Fung; Ping-Chung Leung; Ning-Hua Tan; Clara B S Lau
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  Refractoriness of STING therapy is relieved by AKT inhibitor through effective vascular disruption in tumour.

Authors:  Seung-Hwan Jeong; Myung Jin Yang; Seunghyeok Choi; JungMo Kim; Gou Young Koh
Journal:  Nat Commun       Date:  2021-07-20       Impact factor: 14.919

3.  Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression.

Authors:  Ssang-Taek Lim; Nichol L G Miller; Xiao Lei Chen; Isabelle Tancioni; Colin T Walsh; Christine Lawson; Sean Uryu; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  J Cell Biol       Date:  2012-06-25       Impact factor: 10.539

4.  The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.

Authors:  Gian Carlo Alghisi; Lionel Ponsonnet; Curzio Rüegg
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

5.  Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis.

Authors:  Yunsha Zhang; Weiling Pu; Mélanie Bousquenaud; Sarah Cattin; Jelena Zaric; Li-Kang Sun; Curzio Rüegg
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

6.  MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis.

Authors:  Begoña Alday-Parejo; Kedar Ghimire; Oriana Coquoz; Gioele W Albisetti; Luca Tamò; Jelena Zaric; Jimmy Stalin; Curzio Rüegg
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

7.  Identification of miRNA-mRNA Pairs in Relation to TNF-α/IL-1β Induced Inflammatory Response in Intervertebral Disc Degeneration.

Authors:  Ye Wei; Yulin Chen; Han Su; Chunyan Ling; Guangtian Huang; Dongling Wang; Guanghui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-12       Impact factor: 2.650

8.  The Roles of TNF Signaling Pathways in Metabolism of Bone Tumors.

Authors:  Haiying Zhou; Yanzhao Dong; Ahmad Alhaskawi; Jingtian Lai; Zewei Wang; Sohaib Hasan Abdullah Ezzi; Vishnu Goutham Kota; Mohamed Hasan Abdulla Hasan Abdulla; Zhenyu Sun; Hui Lu
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

9.  The actin filament cross-linker L-plastin confers resistance to TNF-alpha in MCF-7 breast cancer cells in a phosphorylation-dependent manner.

Authors:  Bassam Janji; Laurent Vallar; Ziad Al Tanoury; François Bernardin; Guillaume Vetter; Elisabeth Schaffner-Reckinger; Guy Berchem; Evelyne Friederich; Salem Chouaib
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

10.  Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling.

Authors:  Barbara Valentinis; Simona Porcellini; Claudia Asperti; Manuela Cota; Dan Zhou; Paola Di Matteo; Gianpiero Garau; Chiara Zucchelli; Nilla Roberta Avanzi; Gian Paolo Rizzardi; Massimo Degano; Giovanna Musco; Catia Traversari
Journal:  Int J Mol Sci       Date:  2019-09-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.